E. Gumustepe Et Al. , "Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).," American journal of clinical oncology , no.00, 2024
Gumustepe, E. Et Al. 2024. Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).. American journal of clinical oncology , no.00 .
Gumustepe, E., Yavas, G., Kirakli, E. K., Dincbas, F. Ö., N, D., Hurmuz, P., ... Köksoy, E. B.(2024). Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).. American journal of clinical oncology , no.00.
Gumustepe, Esra Et Al. "Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).," American journal of clinical oncology , no.00, 2024
Gumustepe, Esra Et Al. "Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).." American journal of clinical oncology , no.00, 2024
Gumustepe, E. Et Al. (2024) . "Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).." American journal of clinical oncology , no.00.
@article{article, author={Esra Gumustepe Et Al. }, title={Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).}, journal={American journal of clinical oncology}, year=2024}